Skip links

PEDMARK® (sodium thiosulfate injection)

Full Name PEDMARK® (sodium thiosulfate injection)
Drug Pedmark
Manufacturer Fennec Pharmaceuticals
Route of Administration Intravenous
Site of Care Home or Healthcare Facility
Approved Indication Reduce the risk of ototoxicity associated with cisplatin in pediatric patients 1 month of age and older with localized, non-metastatic solid tumors
Disease Ototoxicity associated with cisplatin
Therapeutic Area Otolaryngology
Enrollment Form Link Pedmark Enrollment Form
Phone Number 800-385-8596
Fax Number 877-694-2545
Product Website